Diabetes Therapies Global Market Opportunities And Strategies To 2023

Mar 2019| TBR035A| TBRC (Publisher)

Report Highlights

Including: Injectables, Oral

Covering: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG

Diabetes Therapies Global Market Opportunities And Strategies To 2023 report from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global diabetes therapies market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the diabetes therapies market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes therapies market opportunities and strategies to 2023 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Market Characteristics – The market characteristics section of the report defines and explains the diabetes therapies market. This chapter includes different goods and services covered in the report, basic definitions and market supply chain analysis.
  • Global Market Size And Growth – This section contains the global historic (2014-2018) and forecast (2018-2023) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.

 

  • Trends And Strategies – This chapter includes some of the major trends shaping the global diabetes therapies market by segment. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

 

 

  • Global Market Segmentation – This section contains global segmentation of the diabetes therapies market for 2018. Segmentation types include by region and by country segmentation of the diabetes therapies market.

 

 

  • Global Macro Comparison – The global diabetes therapies market comparison with macro-economic factors gives the diabetes therapies market size, percentage of GDP, and average diabetes therapies market expenditure.

 

  • Region/Country Market Size And Growth – This section contains the region’s market size (2018), historic (2014-2018) and forecast (2018-2023) market value, and growth. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa) and major countries within each region.
  • Competitive Landscape – This section covers details on the competitive landscape of the global diabetes therapies market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Opportunities And Strategies – This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Scope

Markets Covered: Injectables, Oral

Companies Mentioned: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG

Countries: China, Japan, India, Australia, USA, Brazil, UK, Germany, France, Spain, Italy, Russia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Diabetes Therapies Market, Historic Market Size, 2014– 2018, $ Billion
  • Table 2 : Global Diabetes Therapies Market, Forecast Market Size, 2018– 2023, $ Billion
  • Table 3 : Global Diabetes Therapies Market, by Segment, 2018(%/$ Billions)
  • Table 4 : Global Diabetes Therapies Historic and Forecast Market Growth Rate, by Segment, Through 2023
  • Table 5 : Global Diabetes Therapies Market, 2018, Split By Region
  • Table 6 : Global Diabetes Therapies Market, 2014-2023, Historic And Forecast Growth Rate, Split By Region
  • Table 7 : Global Diabetes Therapies Market, by Country, 2018 (Billions)
  • Table 8 : Global Diabetes Therapies Historic and Forecast Market Growth Rate, by Country, 2014-2023 (%)
  • Table 9 : Global Diabetes Therapies Market Value, Market Size As A Percentage Of Global GDP, 2014 – 2023
  • Table 10 : Global Diabetes Therapies Market, Per Capita Average Diabetes Therapies Market Expenditure, 2014-2023, ($)
  • Table 11 : Asia-Pacific Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 12 : Asia-Pacific Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 13 : Asia-Pacific Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 14 : Chinese Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 15 : Chinese Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 16 : Chinese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 17 : Indian Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 18 : Indian Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 19 : Indian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 20 : Japanese Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 21 : Japanese Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 22 : Japanese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 23 : Australia Diabetes Therapies Market, 2014-2023, ($ Millions)
  • Table 24 : Australia Diabetes Therapies Market, by Segment, 2018 (%/$ Millions)
  • Table 25 : Australia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 26 : Western Europe Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 27 : Western Europe Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 28 : Western Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 29 : UK Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 30 : UK Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 31 : UK Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 32 : German Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 33 : German Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 34 : German Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 35 : French Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 36 : French Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 37 : French Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 38 : Italian Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 39 : Italian Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 40 : Italian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 41 : Spain Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 42 : Spain Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 43 : Spain Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 44 : Eastern Europe Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 45 : Eastern Europe Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 46 : Eastern Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 47 : Russia Diabetes Therapies Market, 2014-2023, ($ Millions)
  • Table 48 : Russia Diabetes Therapies Market, by Segment, 2018 (%/$ Millions)
  • Table 49 : Russia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 50 : North American Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 51 : North American Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 52 : North American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 53 : USA Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 54 : USA Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 55 : USA Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 56 : South American Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 57 : South American Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 58 : South American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 59 : Brazil Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 60 : Brazil Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 61 : Brazil Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 62 : Middle East Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 63 : Middle East Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 64 : Middle East Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 65 : Africa Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 66 : Africa Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 67 : Africa Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 68 : Global Market Shares for Key Competitors of the Diabetes Therapies Market, 2017 ($ Billions/%)
  • Table 69 : Novo Nordisk A/S’s Antidiabetic Drugs Overview
  • Table 70 : Novo Nordisk A/S – Financial Performance, $ Billion
  • Table 71 : Eli Lilly and Company’s Antidiabetic Drugs Overview
  • Table 72 : Amazon – Financial Performance, $ Billion
  • Table 73 : Sanofi S.A.’s Antidiabetic Drugs Overview
  • Table 74 : Sanofi S.A. – Financial Performance, $ Billion
  • Table 75 : Merck & Company, Inc.’s Antidiabetic Drugs Overview
  • Table 76 : Merck & Company, Inc.– Financial Performance, $ Billion
  • Table 77 : C. H. Boehringer Sohn AG & Co. KG’s Antidiabetic Drugs Overview
  • Table 78 : C. H. Boehringer Sohn AG & Co. KG – Financial Performance, $ Billion
  • Table 79 : Diabetic Therapies, Market Size Gain ($ Billion), 2018 – 2023, By Country
  • Table 80 : Diabetic Therapies, Market Size Gain ($ Billion), 2018 – 2023, By Segment
  • Table 81 : Diabetes Therapies Market Data Sources
  • Figure 1 : Diabetes Therapies Market, Supply Chain Analysis
  • Figure 2 : Global Diabetes Therapies Market, Historic Market Size, 2014-2018, $ Billion
  • Figure 3 : Global Diabetes Therapies Market, Forecast Market Size, 2018-2023 , $ Billion
  • Figure 4 : Global Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 5 : Global Diabetes Therapies Historic and Forecast Market Growth Rate, by Segment, 2014-2023
  • Figure 6 : Global Diabetes Therapies Market, 2018, Split By Region
  • Figure 7 : Global Diabetes Therapies Market, 2014-2023, Historic And Forecast Growth Rate, Split By Region
  • Figure 8 : Global Diabetes Therapies Market, by Country, 2018 (%)
  • Figure 9 : Global Diabetes Therapies Market Historic and Forecast Growth Rate, by Country, 2014-2023 (%)
  • Figure 10 : Asia-Pacific Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 11 : Asia-Pacific Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 12 : Asia-Pacific Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 13 : Chinese Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 14 : Chinese Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 15 : Chinese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 16 : Indian Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 17 : Indian Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 18 : Indian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 19 : Japanese Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 20 : Japanese Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 21 : Japanese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 22 : Australia Diabetes Therapies Market, 2014-2023 ($ Millions)
  • Figure 23 : Australia Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 24 : Australia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 25 : Western Europe Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 26 : Western Europe Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 27 : Western Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 28 : UK Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 29 : UK Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 30 : UK Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 31 : German Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 32 : German Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 33 : German Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 34 : French Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 35 : French Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 36 : French Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 37 : Italian Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 38 : Italian Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 39 : Italian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 40 : Spain Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 41 : Spain Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 42 : Spain Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 43 : Eastern Europe Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 44 : Eastern Europe Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 45 : Eastern Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 46 : Russia Diabetes Therapies Market, 2014-2023 ($ Millions)
  • Figure 47 : Russia Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 48 : Russia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 49 : North American Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 50 : North American Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 51 : North American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 52 : USA Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 53 : USA Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 54 : USA Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 55 : South American Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 56 : South American Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 57 : South American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 58 : Brazil Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 59 : Brazil Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 60 : Brazil Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 61 : Middle East Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 62 : Middle East Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 63 : Middle East Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 64 : Africa Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 65 : Africa Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 66 : Africa Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 67 : Global Market Shares for Key Competitors of the Diabetes Therapies Market, 2017, (%)
  • Figure 68 : Novo Nordisk A/S – Financial Performance, $ Billion
  • Figure 69 : Eli Lilly and Company – Financial Performance, $ Billion
  • Figure 70 : Sanofi S.A. – Financial Performance, $ Billion
  • Figure 71 : Merck & Company, Inc. – Financial Performance, $ Billion
  • Figure 72 : C. H. Boehringer Sohn AG & Co. KG – Financial Performance, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

The Business Research Company
Price: $4000

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS